Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
BLACKROCK INC BLK |
2,208,078 5.400% |
2,208,078 (New Position) |
Filing History |
| 2021-09-27 06:01 am Unchanged |
2021-08-16 | 13G | Fulcrum Therapeutics, Inc. FULC |
GLAXOSMITHKLINE PLC | 1,785,714 4.500% |
0 (Unchanged) |
Filing History |
| 2021-09-10 09:33 am Purchase |
2021-09-09 | 13G | Fulcrum Therapeutics, Inc. FULC |
FMR CORP | 6,044,763 14.999% |
4,295,027 (+245.47%) |
Filing History |
| 2021-08-10 5:05 pm Purchase |
2021-08-04 | 13G | Fulcrum Therapeutics, Inc. FULC |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,796,918 5.500% |
1,796,918 (New Position) |
Filing History |
| 2021-02-16 3:22 pm Sale |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Point72 Asset Management, L.P. | 1,338,668 4.900% |
-43,340 (-3.14%) |
Filing History |
| 2021-02-16 11:16 am Sale |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Foresite Capital Fund IV, L.P. | 0 0.000% |
-1,500,000 (Position Closed) |
Filing History |
| 2021-02-12 10:12 am Unchanged |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 2,071,409 7.540% |
0 (Unchanged) |
Filing History |
| 2021-02-11 10:23 am Purchase |
2020-12-31 | 13G | Fulcrum Therapeutics, Inc. FULC |
Casdin Capital, LLC | 1,241,176 4.520% |
1,891 (+0.15%) |
Filing History |
| 2021-02-08 10:23 am Purchase |
2021-02-05 | 13G | Fulcrum Therapeutics, Inc. FULC |
FMR CORP | 1,749,736 6.371% |
48,985 (+2.88%) |
Filing History |
| 2020-11-13 09:57 am Purchase |
2020-11-03 | 13G | Fulcrum Therapeutics, Inc. FULC |
RTW Investments, LP | 2,071,409 7.550% |
2,071,409 (New Position) |
Filing History |
| 2020-09-18 5:21 pm Purchase |
2020-09-17 | 13G | Fulcrum Therapeutics, Inc. FULC |
Point72 Asset Management, L.P. | 1,382,008 5.000% |
1,382,008 (New Position) |
Filing History |